New clinical guidelines recognise the emotional burden of diabetes as a critical component of care, with recommendations for ...
AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...
INGREZZA showed a nearly two-fold higher VMAT2 occupancy, consistent with greater potency when compared to AUSTEDO XR (deutetrabenazine) after a single ...
A new generation of entrepreneurs is addressing India's women's health challenges with innovation, empathy, and evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback